Concord Biotech Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by UTPAL SHETH, was filed 22 Nov 2023.
Concord Biotech Limited: what insiders have been doing
Concord Biotech Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). Concord Biotech Limited has had no insider filing for more than a year; the last one goes back to 23 September 2024.
Other companies in the same sector with recent insider buying flagged by our signals: Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- +58.2%Entry ₹1,276.65 · Close at T+365 ₹2,019.30
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Concord Biotech Limited Buy (bullish), based on 5 analysts. Average price target: ₹1,216.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 5,000 shares@ ₹2,168.8016100.0% of flowEquity SharesSEBI:e990ce951b78fdb1b53203dce076aa7118b495fd
- 1,000 shares@ ₹2,109.40100.0% of flowEquity SharesSEBI:7b7feaa0de8fd9495842ad021d967dce3ad8c2e7
- 3,000 shares@ ₹1,734.7857100.0% of flowEquity SharesSEBI:294f1247b70a3704ae884417dfabe3b97fb04a03
- 10,000 shares@ ₹14,404.02100.0% of flowEquity SharesSEBI:b353b3bcb397de3df99fa02ad7ddd66a07b7e9fd
- 10,000 sharesEquity SharesSEBI:76fad06cca2f6d78ec30031030b64bf59dddf4bb
- 4,000 shares@ ₹1,499.5222100.0% of flowEquity SharesSEBI:e5899ea66ea34ea65ffd381b7881218dc523df98
- 2,000 shares@ ₹1,492.3655100.0% of flowEquity SharesSEBI:535b1450dbfedde6757dc792e8fa353c0c5ba028
- 253 shares@ ₹1,231.023713.6% of flowEquity SharesSEBI:7d5b6426b4fb3fb50e4e416d6a97fb0c565b35faCanonical exit: 18 Feb 2024 (T+90)
- 1,468 shares@ ₹1,319.814786.4% of flowEquity SharesSEBI:547ca22ef8553f6ece3118dc0cb9767ff886d28fCanonical exit: 11 Feb 2024 (T+90)
9 of 9 declarations
About Concord Biotech Limited
Concord Biotech Limited is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XBOM market.
